LEP and obesity disorder: The natural compounds withaferin A and celastrol belong to this class of leptin sensitizers[25, 29, 38] and anti‐ALL agents.[39] Our study thus supports GSK‐J4 as another candidate that possesses potential benefits for both obesity and ALL.